Research progress on the mechanism of mesenchymal stem cells therapy for premature ovarian failure

Abstract

Premature ovarian failure (POF) is a gynecological endocrine disease caused by ovarian dysfunction. Mesenchymal stem cells (MSCs) can effectively treat premature ovarian failure, and play a role in repairing ovarian structure and improving ovarian function. The specific mechanism can be a direct differentiation into granulosa cells or inhibition of their apoptosis through the homing effect of MSCs or differentiate into primordial germ cells. Benefit of MSCs can also be attributed to ovarian angiogenesis promotion, immune regulation, reduce oxidative stress response and paracrine, all potentially promote recovery of ovarian function, and thus improve the fertility of women of childbearing age.

Keywords

• premature ovarian failure (pof)|mesenchymal stem cells (mscs)